Nanotechnology-driven Epigenetic Cancer Therapy: Precision Delivery and Sustained Release of DNA Methylation Modulators
The Yale Journal of Biology and Medicine · 2025
DOI: 10.59249/gvnm8843 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The Yale Journal of Biology and Medicine, 2025. Verfasst von Usama Ahmad und 3 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmacy, Integral University, Lucknow, India. Hauptthemen laut MEDLINE: Neoplasms, DNA Methylation, Epigenesis, Genetic, Nanotechnology. Die Arbeit wurde bisher 15-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Pharmacy, Integral University, Lucknow, India.
Zitieren
APA
Ahmad, U., Islam, A., Khan, M. M., & Akhtar, J. (2025). Nanotechnology-driven Epigenetic Cancer Therapy: Precision Delivery and Sustained Release of DNA Methylation Modulators. The Yale Journal of Biology and Medicine. https://doi.org/10.59249/gvnm8843
Vancouver
Ahmad U, Islam A, Khan MM, Akhtar J. Nanotechnology-driven Epigenetic Cancer Therapy: Precision Delivery and Sustained Release of DNA Methylation Modulators. The Yale Journal of Biology and Medicine. 2025. doi:10.59249/gvnm8843
BibTeX
@article{Ahmad2025,
author = {Ahmad, Usama and Islam, Anas and Khan, Mohd Muazzam and Akhtar, Juber},
title = {Nanotechnology-driven Epigenetic Cancer Therapy: Precision Delivery and Sustained Release of DNA Methylation Modulators},
journal = {The Yale Journal of Biology and Medicine},
year = {2025},
doi = {10.59249/gvnm8843}
}
EUVIMED